XML 57 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Schedule II - Condensed Financial Information
12 Months Ended
Dec. 31, 2017
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
Condensed Financial Information of Parent Company Only Disclosure
SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT

Condensed Balance Sheets
 
 
 
 
 
December 31,
 
2017
 
2016
Assets
 
 
 
Fixed maturities, available for sale, at fair value
$
26,583

 
$

Cash and cash equivalents
79,331

 
7,399

Investment in subsidiaries
579,313

 
263,712

Goodwill
10,157

 
10,841

Property and equipment, net
7,761

 
7,993

Other assets
12,439

 
11,337

Total Assets
$
715,584

 
$
301,282

 
 
 
 
Liabilities
 
 
 
Intercompany payable
$
26,128

 
$
14,531

Accounts payable and accrued expenses
967

 
520

Other liabilities

 
1,906

Long-term notes payable
151,364

 
42,998

Total Liabilities
178,459

 
59,955

 
 
 
 
Stockholders’ Equity
 
 
 
Common stock
4

 
2

Additional paid-in capital
387,145

 
99,353

Treasury stock
(431
)
 
(431
)
Accumulated other comprehensive income
9,221

 
822

Retained earnings
141,186

 
141,581

Total Stockholders’ Equity
537,125

 
241,327

Total Liabilities and Stockholders’ Equity
$
715,584

 
$
301,282


SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT, CONTINUED
Condensed Statements of Comprehensive Income
 
 
 
 
 
 
 
Years Ended December 31,
 
2017
 
2016
 
2015
Revenues
 
 
 
 
 
Net income from subsidiaries (equity method)
$
14,000

 
$
13,296

 
$
27,562

Net realized investment (loss) gain

 
(14
)
 
951

Net investment income
53

 
88

 
239

Total revenues
14,053

 
13,370

 
28,752

 
 
 
 
 
 
Expenses
 
 
 
 
 
Operating and underwriting
348

 
337

 
138

General and administrative
9,078

 
11,805

 
1,252

Interest expense
2,939

 
496

 

Total expenses
12,365

 
12,638

 
1,390

Income before other income
1,688

 
732

 
27,362

Other income
75

 
60

 
245

Income before income taxes
1,763

 
792

 
27,607

Provision for income tax (benefit) expense
(8,382
)
 
(4,906
)
 
249

Net income
$
10,145

 
$
5,698

 
$
27,358

Unrealized gain (loss) on investments
10,647
 
(629
)
 
(3,070
)
Reclassification adjustments - losses (gains)
(67
)
 
(547
)
 
(827
)
Income tax (expense) benefit related to other items of comprehensive income
(2,181
)
 
378

 
1,506

Total Comprehensive Income
$
18,544

 
$
4,900

 
$
24,967


SCHEDULE II. CONDENSED FINANCIAL INFORMATION OF REGISTRANT, CONTINUED
Condensed Statements of Cash Flows
 
 
 
 
 
 
 
Year Ended December 31,
 
2017
 
2016
 
2015
OPERATING ACTIVITIES
 
 
 
 
 
Net income
$
10,145

 
$
5,698

 
$
27,358

Adjustments to reconcile net income to net cash provided by (used in) operating activities:
 
 
 
 
 
Depreciation and amortization
1,208

 
682

 
74

Net realized investment gains

 
14

 
(951
)
Deferred income taxes, net
(777
)
 
382

 
126

Stock based compensation
2,613

 
1,947

 
1,974

Changes in operating assets and liabilities:
 
 
 
 
 
Accrued investment income

 
3

 
(3
)
Other assets
359

 
(22,553
)
 
450

Accounts payable and accrued expenses
447

 

 

Intercompany payable
11,597

 
5,874

 
2,557

Other liabilities
(1,905
)
 
1,969

 
918

Net cash provided by (used in) operating activities
23,687

 
(5,984
)
 
32,503

INVESTING ACTIVITIES
 
 
 
 
 
Proceeds from sales of investments available for sale

 
34,551

 
19,633

Purchases of investments available for sale
(26,584
)
 
(70
)
 
(53,212
)
Additional investment in subsidiaries
(23,283
)
 
(68,563
)
 
16,276

Cost of property and equipment acquired
(449
)
 
(1,797
)
 
(3,255
)
Net cash used in investing activities
(50,316
)
 
(35,879
)
 
(20,558
)
FINANCING ACTIVITIES
 
 
 
 
 
Tax withholding payment related to net settlement of equity awards
(287
)
 
(270
)
 
(185
)
Proceeds from borrowings
150,000

 
42,951

 

Repayments of borrowings
(38,897
)
 

 

Payments of debt issuance costs
(3,264
)
 

 

Dividends
(8,991
)
 
(4,974
)
 
(4,302
)
Net cash provided by (used in) financing activities
98,561

 
37,707

 
(4,487
)
Increase in cash
71,932

 
(4,156
)
 
7,458

Cash and cash equivalents at beginning of period
7,399

 
11,555

 
4,097

Cash and cash equivalents at end of period
$
79,331

 
$
7,399

 
$
11,555




Notes to Condensed Financial Statements - Basis of Presentation

The Company’s investment in subsidiaries is stated at cost plus equity in the undistributed earnings of subsidiaries since the date of acquisition. The Company’s share of net income of its subsidiaries is included in income using the equity method. These financial statements should be read in conjunction with UPC Insurance’s consolidated financial statements.